Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02229903 · ClinicalTrials.gov registry record · NA
An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD
A NA study, sponsored by Brainsway.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02229903 is a NA study that has completed, run by Brainsway. The registered enrollment target is 100 participants.
The verdict
NCT02229903, a NA study, has completed, sponsored by Brainsway.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the safety and efficacy of the Deep TMS (DTMS) treatment in subjects with OCD. The device technology is based on the application of deep brain TMS by means of repetitive pulse trains at a predetermined frequency. The Brainsway DTMS study is a randomized, 10 week, double blind, multi-center trial comparing active DTMS treatment to sham treatment.
Interventions
- DEVICE Sham Treatment
- DEVICE Active DTMS Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2014-09 |
| Est. Completion | 2017-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02229903
The ClinicalTrials.gov registry entry for NCT02229903 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brainsway, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham Treatment is the first listed.
NCT02229903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02229903 about?
NCT02229903 is a clinical study titled "An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD". The purpose of the study is to evaluate the safety and efficacy of the Deep TMS (DTMS) treatment in subjects with OCD. The device technology is based on the application of deep brain TMS by means of repetitive pulse trains at a predetermined frequency. The Brainsway DTMS study is a randomized, 10 we...
What is the current status of trial NCT02229903?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2014-09. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02229903?
The interventions under investigation include: Sham Treatment (DEVICE), Active DTMS Treatment (DEVICE).
Who is sponsoring clinical trial NCT02229903?
This trial is sponsored by Brainsway, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.